X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Unichem Lab with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 UNICHEM LAB   TEVA PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-18
TEVA PHARMA
Dec-13
UNICHEM LAB/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs3822,973-   
Low Rs2342,583-   
Sales per share (Unadj.) Rs116.31,706.3-  
Earnings per share (Unadj.) Rs-18.9106.6-  
Cash flow per share (Unadj.) Rs-11.7244.5-  
Dividends per share (Unadj.) Rs5.0093.31-  
Dividend yield (eoy) %1.63.4 48.3%  
Book value per share (Unadj.) Rs381.01,895.4-  
Shares outstanding (eoy) m70.34848.00-   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.61.6 162.7%   
Avg P/E ratio x-16.326.1 -62.5%  
P/CF ratio (eoy) x-26.211.4 -231.0%  
Price / Book Value ratio x0.81.5 55.2%  
Dividend payout %-26.487.5 -30.2%   
Avg Mkt Cap Rs m21,6682,355,719 0.9%   
No. of employees `0002.344.9 5.1%   
Total wages/salary Rs m2,0060-   
Avg. sales/employee Rs Th3,587.832,194.2 11.1%   
Avg. wages/employee Rs Th880.00-   
Avg. net profit/employee Rs Th-583.72,011.1 -29.0%   
INCOME DATA
Net Sales Rs m8,1801,446,966 0.6%  
Other income Rs m6100-   
Total revenues Rs m8,7901,446,966 0.6%   
Gross profit Rs m-1,320396,252 -0.3%  
Depreciation Rs m505116,960 0.4%   
Interest Rs m8028,421 0.3%   
Profit before tax Rs m-1,295250,872 -0.5%   
Minority Interest Rs m01,140 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0-164,684 0.0%   
Tax Rs m33-3,063 -1.1%   
Profit after tax Rs m-1,33190,391 -1.5%  
Gross profit margin %-16.127.4 -58.9%  
Effective tax rate %-2.6-1.2 211.3%   
Net profit margin %-16.36.2 -260.5%  
BALANCE SHEET DATA
Current assets Rs m23,318977,276 2.4%   
Current liabilities Rs m4,635852,267 0.5%   
Net working cap to sales %228.48.6 2,643.6%  
Current ratio x5.01.1 438.7%  
Inventory Days Days12291 134.1%  
Debtors Days Days12196 126.6%  
Net fixed assets Rs m8,163472,611 1.7%   
Share capital Rs m1413,562 4.0%   
"Free" reserves Rs m26,6600-   
Net worth Rs m26,8011,607,305 1.7%   
Long term debt Rs m3739,866 0.0%   
Total assets Rs m31,8903,306,782 1.0%  
Interest coverage x-15.29.8 -154.4%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.30.4 58.6%   
Return on assets %-3.93.6 -109.2%  
Return on equity %-5.05.6 -88.3%  
Return on capital %-4.54.9 -92.1%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m4,3560-   
CASH FLOW
From Operations Rs m-1,123230,572 -0.5%  
From Investments Rs m16,487-81,701 -20.2%  
From Financial Activity Rs m-8,811-276,586 3.2%  
Net Cashflow Rs m6,552-127,715 -5.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 71.23 Rs / USD

Compare UNICHEM LAB With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare UNICHEM LAB With: NOVARTIS  SANOFI INDIA  DISHMAN PHARMA  ABBOTT INDIA  PLETHICO PHARMA  



Today's Market

Sensex Ends 404 Points Higher; Metal and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets continued their momentum during closing hours and ended the day on a strong note. Gains were largely seen in the metal sector and oil & gas sector.

Related Views On News

UNICHEM LAB Announces Quarterly Results (3QFY19); Net Profit Up 110.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, UNICHEM LAB has posted a net profit of Rs 63 m (up 110.9% YoY). Sales on the other hand came in at Rs 2 bn (up 53.8% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

The RCom Bankruptcy: 5 Lessons for Smallcap Investors(Profit Hunter)

Feb 7, 2019

Managements of companies can create or ruin their fortunes. Why is management quality such an important factor in valuing businesses? Read on to find out...

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

How We Pick the Most Profitable Stocks from the Portfolios of Super Investors(The 5 Minute Wrapup)

Feb 8, 2019

This is the trick to following super investors and not losing money.

Don't Be Afraid of the Market; Buy Stocks Like This One(The 5 Minute Wrapup)

Feb 14, 2019

During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Feb 20, 2019 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS